Drug Profile
Pneumococcal polysaccharide conjugate vaccine - Abcombi Biosciences
Alternative Names: Pneumococcal vaccine - Abcombi BiosciencesLatest Information Update: 12 Oct 2023
Price :
$50
*
At a glance
- Originator Abcombi Biosciences
- Class Conjugate vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 12 Oct 2023 Discontinued - Preclinical for Pneumococcal infections (Prevention) in USA (Parenteral) (Abcombi Biosciences website, October 2023)
- 28 Jun 2020 No recent reports of development identified for preclinical development in Pneumococcal-infections(Prevention) in USA (Parenteral)
- 20 Oct 2017 Immunogenicity data from a preclinical trial in Pneumococcal infections released by Abcombi Biosciences